Unknown

Dataset Information

0

Type 2 Diabetes Mellitus Is Associated with Strongyloides stercoralis Treatment Failure in Australian Aboriginals.


ABSTRACT:

Objective

To explore the efficacy of ivermectin in the treatment of serologically diagnosed cases of Strongyloides stercoralis (S. stercoralis) infection in an Aboriginal community and to describe factors that may influence the outcome of treatment.

Methods

Longitudinal study of a group of 92 individuals with serologically diagnosed S. stercoralis treated with ivermectin and followed up over a period of approximately 6 months. Main outcomes were serological titers pre and post treatment, diabetic status, and duration of follow up.

Findings

Treatment success was achieved in 62% to 79% of cases dependent on the methods employed for the diagnosis of infection and assessment of treatment outcome. Type 2 Diabetes Mellitus (T2DM) was found to be significantly associated with treatment failure in this group for two of the three methods employed.

Interpretation

Ivermectin has been confirmed as an effective treatment for S stercoralis infection in this setting. T2DM appears to be an independent risk factor for treatment failure in this population, and plausible mechanisms to explain this observation are presented.

SUBMITTER: Hays R 

PROVIDER: S-EPMC4546619 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

Type 2 Diabetes Mellitus Is Associated with Strongyloides stercoralis Treatment Failure in Australian Aboriginals.

Hays Russell R   Esterman Adrian A   McDermott Robyn R  

PLoS neglected tropical diseases 20150821 8


<h4>Objective</h4>To explore the efficacy of ivermectin in the treatment of serologically diagnosed cases of Strongyloides stercoralis (S. stercoralis) infection in an Aboriginal community and to describe factors that may influence the outcome of treatment.<h4>Methods</h4>Longitudinal study of a group of 92 individuals with serologically diagnosed S. stercoralis treated with ivermectin and followed up over a period of approximately 6 months. Main outcomes were serological titers pre and post tre  ...[more]

Similar Datasets

| S-EPMC4794948 | biostudies-literature
| PRJNA678007 | ENA
| PRJNA602131 | ENA
| PRJDB5112 | ENA
| PRJNA132425 | ENA
| PRJNA158187 | ENA
| S-EPMC4177786 | biostudies-literature
| S-EPMC7281600 | biostudies-literature
| S-EPMC3678435 | biostudies-literature
| S-EPMC7116469 | biostudies-literature